Regenstrief Institute celebrates women in leadership who drive innovation, advance research and shape the future of healthcare. We recognize their contributions and commitment to improving health and healthcare for all.
Regenstrief Institute, Inc.
研究服务
Indianapolis,IN 6,217 位关注者
Research to transform health systems and communities for a healthier, more equitable world.
关于我们
Regenstrief Institute, Inc., an international leader in electronic medical records and health care data integration, is a medical research and development organization focused on improving quality of care, efficiency of health care delivery, and enhancing patient outcomes. Research focuses include informatics, aging and health services. The Regenstrief Institute, Inc. is a not-for-profit health care research organization located in downtown Indianapolis, Indiana. It is closely affiliated with the Indiana University School of Medicine, Roudebush VA Medical Center, IU Health, and Eskenazi Health among other research partners. Be sure to visit the website, https://www.regenstrief.org, to see more of its work to improve global healthcare.
- 网站
-
https://www.regenstrief.org
Regenstrief Institute, Inc.的外部链接
- 所属行业
- 研究服务
- 规模
- 201-500 人
- 总部
- Indianapolis,IN
- 类型
- 非营利机构
- 创立
- 1969
- 领域
- Medical Informatics、Healthcare Research、Interoperability、Implementation Science、Health Services Research和Aging Research
地点
Regenstrief Institute, Inc.员工
动态
-
Atrial fibrillation (AFib) often goes undetected until serious complications arise. UNAFIED, an AI-powered risk prediction model developed by researchers including Regenstrief Institute's Randall Grout, M.D., M.S., integrates seamlessly into clinical workflows to help identify at-risk patients early. By leveraging electronic health record data, this tool enables proactive screening, supporting better patient care. Other partners include Eskenazi Health, Pfizer, IU School of Medicine and Franciscan Physician Network https://lnkd.in/gnyWApDX
-
-
Regenstrief Institute was well represented at the INSPIRE Benefit, the Alzheimer's Association Greater Indiana Chapter’s signature brunch, alongside influential leaders dedicated to advancing Alzheimer’s and dementia research. The event highlighted the critical work happening in Indianapolis to support caregivers, drive research and shape the future of brain health. Rachel Patzer Nicole Fowler Alexia Torke Susan Hickman Christopher Callahan Malaz Boustani Noll Campbell
-
-
A study involving Regenstrief highlights the lack of consensus among experts on continuing vs. discontinuing long-term opioid therapy for chronic pain. The findings emphasize the complexities of pain management and the need for shared decision-making between clinicians and patients. https://lnkd.in/gyYzsqei
-
-
Regenstrief Institute, IU School of Medicine and IU Health researchers helped develop a standardized goals of care note in EHRs, making critical patient preference information easier to access. The study highlights how structured documentation improves communication, supports decision-making and enhances end-of-life care. https://lnkd.in/gzk8YKUt
-
-
A study team including Regenstrief Institute and IU Indianapolis Fairbanks School of Public Health examines how to better identify emergency department patients with health-related social needs. Researchers found that a machine learning model leveraging electronic health record data was more effective than screening surveys at predicting future needs. Emergency department patients were studied because many of these patients are more likely to fall through the cracks due to lack of comprehensive health insurance, transportation barriers, financial insecurity or not having a doctor to address the condition that brought them to seek care. https://lnkd.in/gRGwQctY
-
-
Dr. Clint Cary discusses groundbreaking research for lymph node removal reaffirming the gold standard of care, highlighting the value of high-volume centers, and establishing a benchmark for evaluating new technologies and innovations. https://lnkd.in/gKnZSNNh
-
Metastatic breast cancer survivors face significant challenges with fatigue, which affects up to 63% of patients. Regenstrief Institute researchers, in collaboration with Indiana University and other partners, found that telephone-delivered acceptance and commitment therapy can reduce fatigue interference and improve quality of life. This novel behavioral intervention, focused on mindfulness and psychological flexibility, also shows promise in improving sleep quality. https://lnkd.in/gcNrkTjc
-
-
By integrating palliative care with dementia care, the IN-PEACE study reduced emergency visits and hospitalizations by 50 percent, especially benefiting African American individuals and those with lower incomes. This study published in JAMA highlights the transformative impact of IN-PEACE. Regenstrief’s Greg Sachs, M.D., led the clinical trial along with colleagues from IU School of Medicine. Other partners included IU School of Medicine Division of General Internal Medicine and Geriatrics, IU Health, IU Health Physicians, IU School of Nursing, IU School of Medicine Department of Biostatistics and Health Data Science.? https://lnkd.in/g6Sx7QYZ
-
-
Congratulations on the launch of the IU LAB. Mentorship and training are key components to Regenstrief’s work. “IU LAB will play a critical role in advancing life and biosciences innovation to address our state’s most critical health challenges,” said Dr. Rachel Patzer.?
The future of bioscience innovation is here. Today, we celebrated the official launch of IU Launch Accelerator for Biosciences (IU LAB) at 16 Tech Innovation District in Indianapolis. This first-of-its-kind academic-industry initiative, supported by a $138 million Lilly Endowment Inc. grant, will serve as a dynamic hub, driving collaboration between Indiana University and industry in critical areas of bioscience and health research, establishing Indiana as a global leader in bioscience innovation. We were honored to be joined by Governor Braun, Mayor Hogsett, David Rosenberg (the new president and CEO of IU LAB), Cook Medical President Pete Yonkman, and leaders from the Indiana Biosciences Research Institute, Regenstrief Institute, Inc., Indiana University Health, and Central Indiana Corporate Partnership. Their collaboration will ensure IU LAB thrives as a hub of innovation, driving advancements in healthcare, creating pathways for the next generation of bioscience leaders, and fueling the development of one of our state’s most vital industry sectors. IU LAB’s mission goes beyond research—it is about making a tangible impact on human health and transforming the local community. By fostering academic-industry partnerships, providing educational opportunities, and supporting IU entrepreneurs developing new startup companies, IU LAB will accelerate the commercialization of new biosciences discoveries and help empower local residents with career opportunities. This launch further solidifies Indiana University Indianapolis’ status as a premier urban research institution, amplifying its role as a leader in bioscience innovation and community transformation. It marks a pivotal moment in realizing the ambitious goals of the IU 2030 strategic plan, setting the stage for Indiana to lead in bioscience research and innovation. AcceLINX Adipo Therapeutics Aurorium BioCrossroads Eli Lilly and Company Hoosier Cancer Research Network INCOG BioPharma Services Indiana CTSI myBiometry OrthoWorx, Inc. Plug and Play Tech Center